CRIS Current Research Information System

PINNA, ANTONIO DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.744
EU - Europa 16.804
AS - Asia 9.037
AF - Africa 1.241
SA - Sud America 62
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 11
Totale 53.919
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.673
GB - Regno Unito 5.460
CN - Cina 3.235
VN - Vietnam 2.633
SE - Svezia 2.256
DE - Germania 2.250
IT - Italia 1.985
SG - Singapore 1.721
UA - Ucraina 1.137
IN - India 1.037
IE - Irlanda 822
FR - Francia 733
RU - Federazione Russa 713
ZA - Sudafrica 463
EE - Estonia 427
TG - Togo 341
CH - Svizzera 290
CI - Costa d'Avorio 238
BG - Bulgaria 213
JO - Giordania 161
FI - Finlandia 122
NG - Nigeria 119
BE - Belgio 95
SC - Seychelles 67
CA - Canada 65
IR - Iran 58
JP - Giappone 58
GR - Grecia 52
AT - Austria 37
NL - Olanda 37
ES - Italia 36
BR - Brasile 34
RO - Romania 33
PL - Polonia 24
HR - Croazia 22
TR - Turchia 22
CL - Cile 20
LB - Libano 20
AU - Australia 15
HK - Hong Kong 15
UZ - Uzbekistan 15
CZ - Repubblica Ceca 11
MY - Malesia 9
DK - Danimarca 8
NO - Norvegia 8
PT - Portogallo 8
EU - Europa 7
KR - Corea 7
PK - Pakistan 7
IL - Israele 5
MK - Macedonia 5
NZ - Nuova Zelanda 5
PE - Perù 5
PH - Filippine 5
SK - Slovacchia (Repubblica Slovacca) 5
A2 - ???statistics.table.value.countryCode.A2??? 4
ET - Etiopia 4
AE - Emirati Arabi Uniti 3
BD - Bangladesh 3
KH - Cambogia 3
LK - Sri Lanka 3
MD - Moldavia 3
SA - Arabia Saudita 3
AL - Albania 2
DZ - Algeria 2
GE - Georgia 2
HU - Ungheria 2
LT - Lituania 2
LU - Lussemburgo 2
MA - Marocco 2
MM - Myanmar 2
SI - Slovenia 2
TH - Thailandia 2
TN - Tunisia 2
TW - Taiwan 2
UG - Uganda 2
AM - Armenia 1
AR - Argentina 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
BZ - Belize 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
ID - Indonesia 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MO - Macao, regione amministrativa speciale della Cina 1
PA - Panama 1
PR - Porto Rico 1
PY - Paraguay 1
Totale 53.919
Salva come PNG Salva come JPEG
Città #
Southend 5.014
Fairfield 3.993
Chandler 2.306
Ashburn 2.180
Woodbridge 1.988
Dong Ket 1.785
Houston 1.728
Wilmington 1.724
Seattle 1.591
Singapore 1.479
Cambridge 1.427
Princeton 1.203
Ann Arbor 1.053
Dublin 771
Jacksonville 658
Nanjing 549
Westminster 529
Padova 480
Bologna 373
Berlin 364
Lomé 341
Santa Clara 287
Saint Petersburg 268
Bern 256
Jinan 249
Shenyang 239
Abidjan 238
San Diego 231
Sofia 211
Beijing 180
New York 170
Hebei 165
Dearborn 164
Nanchang 163
Amman 161
Changsha 159
Turin 147
Mülheim 139
Florence 135
Medford 133
Helsinki 121
Abeokuta 118
Tianjin 113
Jiaxing 112
Menlo Park 112
Boardman 108
Milan 101
Bremen 100
Falls Church 93
Norwalk 93
Brussels 91
Redmond 86
Guangzhou 84
Redwood City 81
Zhengzhou 79
Olalla 78
Hangzhou 73
Des Moines 70
Los Angeles 69
Mahé 63
Ningbo 62
Haikou 60
Lanzhou 56
Tokyo 51
Fuzhou 49
Taizhou 49
Verona 46
Shanghai 42
Toronto 42
Bühl 39
Taiyuan 38
Kunming 35
Mountain View 35
Hefei 31
London 31
Pune 31
San Venanzo 29
Vienna 28
Monmouth Junction 27
Paris 26
Rome 26
Leawood 25
Wuhan 24
Hyderabad 23
São Paulo 21
Phoenix 20
Costa Mesa 19
Frankfurt Am Main 19
Frankfurt am Main 18
San Francisco 18
Xi'an 18
Zanjan 18
Ardabil 17
Chengdu 17
Chicago 16
Fremont 16
Washington 16
Amsterdam 15
Castelnuovo Rangone 15
Kuban 15
Totale 38.259
Salva come PNG Salva come JPEG
Nome #
Asbestos: a hidden player behind the cholangiocarcinoma increase? Findings from a case–control analysis 335
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C 236
Liver transplantation for mitochondrial neurogastrointestinal encephalomyopathy 209
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 208
Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically. 202
A comprehensive analysis on expected years of life lost due to pancreatic cancer 197
Adding Liver Stiffness Measurement to the Routine Evaluation of Hepatocellular Carcinoma Resectability Can Optimize Clinical Outcome 196
Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases. 185
Characterization of pancreatic ductal adenocarcinoma patients using whole-transcriptome sequencing and copy number analysis by SNPs array techniques. 185
Characterization of pancreatic ductal adenocarcinoma using whole transcriptome sequencing and copy number analysis by single-nucleotide polymorphism array 184
A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system. 184
A new liver transplant priority for patients with hepatocellular carcinoma. 182
Burnout and psychological distress between surgical and non-surgical residents 182
Comprehensive surgical intestinal rescue and transplantation program in adult patients: Bologna experience. 175
Antifungal prophylaxis in liver transplant recipients: one size does not fit all 174
Combined liver-kidney transplantation: the experience of the University of Bologna and the case of preoperative positive cross-match. 173
Hepatobiliary Scintigraphy in the Preoperative Evaluation of Potential Living Liver Donors 173
Associated benign liver tumors in idiopathic granulomatous hepatitis: a case report 168
A new prognostic model to predict drop-out from the waiting list in cirrhotic candidates for liver transplantation wirh MELD score <18. 167
Combined liver–dual kidney transplant: Role in expanded donors 166
Combined kidney-liver, heart-liver, and kidney-pancreas transplantations from a single deceased donor. 165
Carbapenem-resistant Klebsiella pneumoniae colonization at liver transplantation:a management challenge 165
Abdominal wall defect repair with biological prosthesis in transplanted patients: single center retrospective analysis and review of the literature 163
Bacterial translocation in adult small bowel transplantation 158
An explorative data-analysis to support the choice between hepatic resection and radiofrequency ablation in the treatment of hepatocellular carcinoma. 158
Acute cellular rejection monitoring after interstinal transplant: utility of serologic markers and zoom videoendoscopy as support of conventional biopsy and clinical findings. 158
Abdominal wall transplantation with microsurgical technique 158
Assessment of Radiofrequency Ablation Efficacy for Hepatocellular Carcinoma by Histology and Pre-transplant Radiology 158
Causes of early acute graft failure after liver transplantation: analysis of a 17-year single-centre experience. 157
Average treatment effect of hepatic resection versus locoregional therapies for hepatocellular carcinoma 157
Long-term endoscopic follow-up in small bowel transplant recipients: single-center series. 156
Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression. 156
A simplified technique for the en-bloc procurement of abdominal organs that is suitable for pancreas and small bowel transplantation. 156
Competing risk analysis on outcome after hepatic resection of hepatocellular carcinoma in cirrhotic patients. 155
Blood monitoring of granzyme B and perforin expression after intestinal transplantation: considerations on clinical relevance. 152
Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers. 151
Can antiplatelet prophylaxis reduce the incidence of hepatic artery thrombosis after liver transplantation? 151
Evaluation of extensive cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with advanced epithelial ovarian cancer. 151
Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center 151
Liver as a Source for Thymidine Phosphorylase Replacement in Mitochondrial Neurogastrointestinal Encephalomyopathy 150
Application of a fluorescent PCR method for molecular diagnosis of posttransplant lymphoproliferative disorders on routine tissue sections. 150
Anticorpi anti-HLA preformati e Trapianto Combinato Rene-Fegato. Caso clinico. 149
Combined liver-kidney transplantation-s. Orsola experience: nephrological aspects. 149
Analysis of 80 dual-kidney transplantations: a multicenter experience. 148
A new liver extracorporeal device (LEONARDO) to treat swine with post-resection acute liver failure 147
A prospective multi-center randomized clinical study to compare the efficacy of ertapenem 3 days versus ampicillin-sulbactam 3 days in the treatment of localized community acquired intra-abdominal infection 147
Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective 147
Genome-wide analysis identifies MEN1 and MAX mutations and a neuroendocrine-like molecular heterogeneity in Quadruple WT GIST 147
Importance of primary indication and liver function between stages: Results of a multicenter Italian audit of ALPPS 2012-2014 146
Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation. 145
Analysis of risk factors for early hepatic artery thrombosis after liver transplantation. Possible contribution of reperfusion in the early morning. 145
Combined heart and liver transplantation for familial amyloidotic polyneuropathy. 145
Assessment of donor steatosis in liver transplantation: is it possible without liver biopsy? 145
ITA-MNGIE: an Italian regional and national survey for mitochondrial neuro-gastro-intestinal encephalomyopathy. 145
Artificial neural network is superior to MELD in predicting mortality of patients with end-stage liver disease. 144
Good survival outcome of metastatic SDH-deficient gastrointestinal stromal tumors harboring SDHA mutations 143
Affidabilità della combinazione di angioecografia perfusionale ed altre tecniche di imaging nella valutazione della trombosi portale in pazienti con epatocarcinoma (HCC) candidati al trapianto di fegato 142
null 142
Phenotypic and genotypic heterogeneity in transthyretin-related cardiac amyloidosis: Towards tailoring of therapeutic strategies? 142
Analysis of cardiovascular, acid-base status, electrolyte and coagulation changes during small bowel transplantation 141
Anatomic variations of intrahepatic bile ducts in a European series and meta-analysis of the literature. 141
Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients. 141
Acute renal failure requiring renal replacement therapy after orthotopic liver transplantation 141
Reliability of imaging techniques in assessing portal venous thrombosis in patients with hepatocellular carcinoma candidates for liver transplantation 141
Membrane localization of human equilibrative nucleoside transporter 1 in tumor cells may predict response to adjuvant gemcitabine in resected cholangiocarcinoma patients 141
Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. 140
DAAs treatment in HCV recurrence after liver transplantation: Clinical usefulness of non-invasive methods 140
Combined Liver-Kidney Transplantation With Preformed Anti-HLA Antibodies: A Case Report. 140
Membrane human equilibrative nucleoside transporter 1 is associated with a high proliferation rate and worse survival in resected intrahepatic cholangiocarcinoma patients not receiving adjuvant treatments 140
COMBINED KIDNEY LIVER TRANSPLANTATION: A SINGLE CENTER EXPERIENCE 139
A Multicentric Study on Double Kidney Transplantation 139
Combined heart-liver transplantation: A single-center experience 139
Combined liver transplants: main characteristics from the standpoint of anesthesia and support in intensive care 138
T.E.A. Study: three-day ertapenem versus three-day Ampicillin-Sulbactam 137
Age and equity in liver transplantation: An organ allocation model. 137
Multimodal Surgical Approach for Adult Patients With Chronic Intestinal Pseudo-Obstruction: Clinical and Psychosocial Long-term Outcomes 137
Italian experience in adult clinical intestinal and multivisceral transplantation: 6 years later. 137
Conventional split liver transplantation for two adult recipients: a recent experience in a single European center 136
Conditional survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients. 136
Coping strategies in intestinal transplantation 136
Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era. 135
Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma. 135
null 135
Impact of preoperative infection on outcome after liver transplantation 135
Imaging in resectable colorectal liver metastasis patients with or without preoperative chemotherapy: results of the PROMETEO-01 study 134
WSES consensus conference: Guidelines for first-line management of intra-abdominal infections. 134
Psychological and Physical Health in Patients with CIPO: Transplant and Non-Transplant Surgery 134
Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft 134
Daclizumab and Alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: A comparison of two different regimens on 29 recipients during the early post-operative period. 134
Efficacy of MELD score in predicting survival after liver retransplantation. 133
Histological recurrent hepatitis C after liver transplantation: Outcome and role of retransplantation. 132
Genomic allelotyping for distinction of recurrent and de novo hepatocellular carcinoma after orthotopic liver transplantation 131
G-CSF administration is not related to Peg-IFN alfa-2b treatment duration nor response in liver transplanted patients with HCV recurrence. 131
Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinoma. 131
Applying of pretreatment extent of disease system in patients with hepatocellular carcinoma after curative partial hepatectomy 131
Iliac Approach for Vascularization of an Intestinal Graft at Retransplantation. 130
Duration of adjuvant treatment following radical resection of metastases from gastrointestinal stromal tumours. 130
Strategies to Restore Adenosine Triphosphate (ATP) Level After More than 20 Hours of Cold Ischemia Time in Human Marginal Kidney Grafts. 130
Management of immunosuppressive therapy in liver transplant recipients who develop bloodstream infection. 130
Using Elderly Donors in Liver Transplantation. 129
Totale 15.340
Salva come PNG Salva come JPEG
Categoria #
all - tutte 136.060
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 136.060
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202012.787 0 0 0 936 1.595 1.669 2.009 2.039 2.146 1.002 563 828
2020/20218.083 1.682 595 258 319 142 341 114 394 632 371 333 2.902
2021/20229.997 1.003 403 591 794 955 535 236 630 356 507 2.252 1.735
2022/202310.191 1.139 1.611 579 1.339 621 705 269 551 1.771 241 861 504
2023/20242.451 202 479 121 264 170 510 117 174 83 171 72 88
2024/20253.448 426 1.858 826 338 0 0 0 0 0 0 0 0
Totale 55.067